IDA
BIIB icon

Intelligence Driven Advisers’s Biogen BIIB Stock Holding History

Intelligence Driven Advisers’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-705
Closed -$201K – 89
2023
Q2 		$201K Sell
705
-40
-5% -$11.9K 0.04% 92
2023
Q1 		$212K Buy
745
+25
+3% +$6.92K 0.04% 88
2022
Q4 		$201K Buy
+720
New +$203K 0.04% 97

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Intelligence Driven Advisers's BIIB Position: Q3 2023 in Review

Intelligence Driven Advisers sold out of Biogen (BIIB) in Q3 2023, closing a stake of 705 shares — an estimated $201K sold.

Intelligence Driven Advisers first reported a position in BIIB in Q4 2022 and held it in 3 quarters. The position peaked at $212K in Q1 2023. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Intelligence Driven Advisers reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • Intelligence Driven Advisers sold 705 Biogen shares in Q3 2023, an estimated $201K.
  • Intelligence Driven Advisers first reported a position in Biogen in Q4 2022 and held it in 3 quarters.
  • Intelligence Driven Advisers's Biogen position peaked at $212K in Q1 2023.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Intelligence Driven Advisers's 13F filing for Q3 2023, filed 7 Nov 2023.